Tag Archives: Taltz

June, 2018

December, 2017

  • 4 December

    Lilly’s Taltz Receives FDA Approval for the Treatment of Active Psoriatic Arthritis

    INDIANAPOLIS, Dec. 1, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment of adults with active psoriatic arthritis (PsA).1 Taltz was first approved by the FDA in March 2016 for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for …

June, 2017

August, 2016

  • 17 August

    A Tricky Time

    Psoriasis comes in several forms, with plaque psoriasis being the most common. Earlier this year, a new medication – Taltz® (ixekizumab) – gained FDA approval as another option for treating moderate-to-severe cases of plaque psoriasis, in which thick, red areas on the skin become flaky with silver-white scales. Taltz, an …

March, 2016

  • 22 March

    FDA Approves Lilly’s Taltz for Treatment of Psoriasis

    The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is a skin condition that causes patches of skin redness and flaking. Psoriasis is an autoimmune disorder that occurs more commonly in patients with a family history of the disease, and most …